ST. PETERSBURG, FL, Nov. 5, 2014 (GLOBE NEWSWIRE) -- FutureWorld Corp. (OTCQB;FWDG), a leading provider of advanced
technologies and solutions to the global cannabis industry,
announces that it has purchased controlling ownership interest in
provisional patent #61/977,514, for Onsite Cannabis THC Potency
Test Kit, from Angela Knittel, CEO of WMII Inc. Mrs. Knittel and
her partners developed a similar process for THC potency and
applied for a provisional patent covering and protecting the
process. With the purchase of their controlling interest in the
provisional patent #61/977,514, CB Scientific has become global
leader in Cannabis personal THC and CBD analytics. The Company is
also in the process of filing provisional patents for its own
developed THC and CBD analytics, strengthening its position as the
first mover and the global leader in cannabis personal
analytics.
Knittel and her company WMII, Inc. (Worldwide Marijuana
Community) has also agreed to become a distribution representative
marketing the PersonalAnalytics THC & CBD Test Kits on behalf
of CB Scientific, a wholly-owned subsidiary of FutureWorld Corp. CB
Scientific expects to sell thousands of the PersonalAnalytics THC
& CBD PocketLabs by the end of 2014 and hundreds of thousands
by the end of 2015.
"Bringing on Ms. Knittel and her company, Worldwide Marijuana
Community, as a distribution representative only strengthens CB
Scientific and FutureWorld Corp. We believe the purchase of Ms.
Knittel's intellectual property helps our company to strengthen its
position as the market leader of 'on the spot' potency testing of
cannabis." said CEO of CB Scientific, Bill Short.
The recent local and national media exposure received by CB
Scientific and FutureWorld for its unique invention of
PersonalAnalytics, the 1st Ever Affordable Home Testing Kits for
THC and CBD, has helped bolster the company's position in the eyes
of medical cannabis patients and growers worldwide. CB Scientific
has had requests for its PersonalAnalytics "PocketLabs" from as far
away as Australia.
A recent review of the Test Kits by HIGH TIMES Magazine has also
shown the kits to be highly accurate and effective in helping
patients and growers to know potency levels of THC and CBD in their
crops and medicine.
http://www.hightimes.com/read/high-buy-cbscientific-personal-analytics-thc-and-cbd-test-kit
The super quick 'on the spot' results of PersonalAnalytics THC
& CBD Test Kits are an effective intermediary between "nothing
or no testing" and "expensive labs" that can take days to get
reports; reports Hightimes magazine.
ABOUT CB SCIENTIFIC
CB Scientific (http://www.cbscientific.com) is a wholly owned
company based in Denver Colorado. CB Scientific is continuing to
develop new technologies specifically for cannabis analytics.
Senior management team includes Charlie Steinberg and Derek Lebahn.
Mr. Steinburg and Mr. Lebahn are some of the primary men advancing
gas chromatography testing in Colorado. Mr. Steinburg has also
pioneered residual solvent testing for medical cannabis and has
always strived to help patients know exactly what they are buying.
CB Scientific believes every product sold to patients as "Medical
Quality" should be inspected for health benefits, safety,
consistency, purity, potency and packaged properly for
distribution.
Senior management team of CB Scientific have worked with many of
the cannabis industry leaders in Colorado and have also been
featured in cannabis industry publications including High Times
Magazine, many trade publications, on-air interviews and panel
discussions across the United States.
CB Scientific's focus has been the education and safety of
consumers combined with innovation to put power into the hands of
the patients. Values that FutureWorld is pleased to embrace while
ever striving to raise the bar of cannabis analytics even
higher.
ABOUT FUTUREWORLD CORP.
FutureWorld (Other OTCQB: FWDG), a Delaware corporation, is a
U.S. Diversified Holding Company formed to capitalize on the
burgeoning Cannabis markets globally. FutureWorld, together with
its subsidiaries, focuses on the identification, acquisition,
development, and commercialization of cannabis related products,
such as industrial Hemp. FutureWorld, through its subsidiaries such
as HempTech and CB Scientific, provides personal and professional
THC and CBD test kits, pure CBD oil solutions, smart sensor
technology, communication network, surveillance security, data
analysis for smart cultivation and consultation for the industrial
hemp and legal medicinal cannabis. Our wireless agricultural smart
sensor networks offer precision to the agriculture, irrigation
systems, and greenhouses for the global cannabis and hemp industry.
FutureWorld and its subsidiaries do not grow, distribute or sell
marijuana. To request further information about FutureWorld, please
email us at info@futureworldcorp.com, log onto our website at
http://www.futureworldcorp.com or visit us at our Facebook page
https://www.facebook.com/futureworldenergy or on Twitter
#futureworldinc.
Forward-Looking Statements
This press release may contain forward-looking statements
covered within the meaning of the Private Securities Litigation
Reform Act of 1995. These forward-looking statements relate to,
among other things, plans and timing for the introduction or
enhancement of our services and products, statements about future
market conditions, supply and demand conditions, and other
expectations, intentions and plans contained in this press release
that are not historical fact and involve risks and uncertainties.
Our expectations regarding future revenues depend upon our ability
to develop and supply products and services that we may not produce
today and that meet defined specifications. When used in this press
release, the words "plan," "expect," "believe," and similar
expressions generally identify forward-looking statements. These
statements reflect our current expectations. They are subject to a
number of risks and uncertainties, including, but not limited to,
changes in technology and changes in pervasive markets. This
release includes forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933 and Section 27E of the
Securities Act of 1934. Statements contained in this release that
are not historical facts may be deemed to be forward-looking
statements. Investors are cautioned that forward-looking statements
are inherently uncertain. Actual performance and results may differ
materially from that projected or suggested herein due to certain
risks and uncertainties including, without limitation, ability to
obtain financing and regulatory and shareholder approval for
anticipated actions.
CONTACT: Media Contact
FutureWorld Corp
Investor Relations
http://www.futureworldcorp.com
info@futureworldcorp.com
cox@futureworldcorp.com
(727) 474-1816 ext. 103
